论文部分内容阅读
我院应用酚妥拉明加硫酸镁治疗重症支气管哮喘病人获得较为满意的疗效,现报道于下。1 临床资料1.1 对象我院1994年1月～2000年4月住院的资料较完整的重症支气管哮喘病人,均符合1997年4月第二届全国哮喘学术会议通过的诊断标准。其中男18例,女10例,年龄21～72岁,平均47.4岁。哮喘发作时间2～9天,平均3.8天。均经急诊室或当地医院应用糖皮质激素、氨茶硷或β_2受体激动剂治疗无明显效果或病情加重住院而采用本方法治疗。另外,以同样标准的重症哮喘患者14例,男9例,女5例,年龄20～64岁,平均49.6岁,作为对照组。
Application of phentolamine plus magnesium sulfate in patients with severe bronchial asthma patients get more satisfactory results, are reported below. 1 Clinical data 1.1 Object Our hospital from January 1994 to April 2000 hospitalized patients with more complete data of severe bronchial asthma are in line with the diagnostic criteria of the Second National Asthma Academic Conference in April 1997. There were 18 males and 10 females, aged 21-72 years with an average of 47.4 years old. Asthma attack time 2 to 9 days, an average of 3.8 days. All patients were treated with glucocorticoids, aminophylline or beta-2 agonists in the emergency department or local hospital without any significant effect or with increased hospitalization. In addition, the same criteria for severe asthma in 14 patients, 9 males and 5 females, aged 20 to 64 years, mean 49.6 years old, as a control group.